Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA September 600x60px

Deals > All

Total search results: 4364 | Ordered by Date (descending)
1 2 3 ... 42 43 44  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Evotec–Berenberg: investor conference, 201712 supply service Evotec presents at Berenberg European Conference in Surrey 2017-12-06
Evotec–Deutsche Börse: investor conference, 201711 supply service Evotec AG presents at Deutsches Eigenkapitalforum 2017 2017-11-27
Evotec–Volks- und Raiffensenbanken (DE): investor conference, 201711 supply service Evotec attends DZ Bank Equity Conference 2017 in Ffm 2017-11-22
Evotec–Leucadia: investor conference, 201711 supply service Evotec AG presents at Jefferies 2017 Global Healthcare Conference London 2017-11-15
Curetis–Ladenburg Thalmann: investor conference, 201709 supply service Curetis presents at Ladenburg Thalmann 2017 Healthcare Conference in NY 2017-09-26
Curetis–Cantor Fitzgerald: investor conference, 201709 supply service Curetis presents at Cantor Fitzegerald Global Healthcare Conference in NY 2017-09-25
Evotec–Baader Bank: investor conference, 201709 supply service Evotec attends Baader Investment Conference 2017 in Munich 2017-09-20
Evotec–Berenberg: investor conference, 201709 supply service Evotec presents at 6th German Corporate Conference in Munich 2017-09-18
Evotec–Goldman Sachs: investor conference, 201709 supply service Evotec presents at 7th Annual Biotech Symposium in London 2017-09-18
Curetis–Rodman & Renshaw: investor conference, 201709 supply service Curetis presents at Rodman & Renshaw Global Investment Conference in NY 2017-09-10
DiaSorin–Siemens: ELISA immunoassays, 201707– acquisition up to €47.5m of Siemens ELISA Dx portfolio/assets without employees + mftg capacity 2017-07-25
NeuroDerm–Mitsubishi Chemical: investment, 201707– acqusition $1.1b in cash $39/share by Mitsubishi Tanabe Pharma Corp ANNOUNCED 2017-07-24
Alligator Bioscience–Aptevo Therapeutics: antibody cancer drug, 201707– collab developm bispecific antibody ALG.APV-527 for I-O 2017-07-21
Boehringer–Philogen: drug discovery services, 201707– collab €na discovery + optimisation of small molecule drugs using ESAC technology 2017-07-20
SpinDiag–SEVERAL: investment, 201707 seed financing round €1.6m from three private investors 2017-07-20
Trevi Therapeutics–Lundbeck: investment, 201707 financing round Series C totalling $50m incl new + co-investor Lundbeckfond Ventures 2017-07-20
Trevi Therapeutics–SEVERAL: investment, 201707 financing round Series C $50m led by NEA + incl Lundbeckfond et al 2017-07-20
OSE Immunotherapeutics–France (govt): grant, 201707 Bpifrance grant €9.2m for developm of checkpoint inhibitor OSE-172 2017-07-19
Shire–Novimmune: therapeutic antibodies, 201707– license ww excl €na to bispecific antibody for hemophilia A 2017-07-18
TomTec Imaging–Philips: investment, 201707– acquisition €na of TomTec Imaging Systems GmbH by Philips ANNOUNCED 2017-07-18
Emergent BioSolutions–Sanofi: smallpox vaccine, 201707– acquisition of ACAM2000 business $97.5m upfront + $27.5m milestones by Emergent 2017-07-14
Silence Therapeutics–FTI Consulting: public relations, 201707 service existent by FTI Consulting 2017-07-14
ABF–Genedata: bioinformatics, 201707– supply expansion use of Genedata Selector by AB Enzymes for decision support 2017-07-11
BioCity (GB)–Alto Marketing: public relations, 201707 service existent for BioAscent Discovery Ltd by Alto Marketing Ltd 2017-07-11
Blueprint Genetics–Creathor Venture: investment, 201707 financing round totalling up to €14m incl new + co-lead investor Creathor Venture 2017-07-11
Blueprint Genetics–Inventure: investment, 201707 financing round totalling up to €14m incl existing + co-investor Inventure 2017-07-11
Blueprint Genetics–MedTech Innovation Partners: investment, 201707 financing round totalling up to €14m incl new + co-lead investor MTIP 2017-07-11
Blueprint Genetics–Pontos Group: investment, 201707 financing round totalling up to €14m incl existing + co-investor Pontos Group 2017-07-11
Blueprint Genetics–SEVERAL: investment, 201707 financing round up to €14m led by Creathor Venture + MTIP + incl Inventure + Pontos Group 2017-07-11
CRISPR Therapeutics–Piper Jaffray: investor conference, 201707 supply service CRISPR Therapeutics presents at Piper Jaffray GenomeRx Symposium in NYC 2017-07-11
Nestlé–Enterome: diagnostics, 201707– collab establishm of 50/50 jv MDP to develop microbiome-based diagnostics except for immuno-oncology 2017-07-11
Protein Sciences–Sanofi: investment, 201707– acquisition $650m upfront + $100m milestones by Sanofi ANNOUNCED 2017-07-11
Amatsigroup–Eurofins: investment, 201707– acquisition €130m plus some residual debt from Ekkio Capital 2017-07-10
CRISPR Therapeutics–Neon Therapeutics: T cell therapy, 201707– collab combi of proprietary technologies to develop T cell therapies 2017-07-10
Freeline Therapeutics–Consilium: public relations, 201707 service existent by CSC 2017-07-10
Neon Therapeutics–Ten Bridge Communications: public relations, 201707 service existent by Ten Bridge 2017-07-10
Cellnovo–Consilium: public relations, 201707 service existentPR in UK by CSC 2017-07-07
Cellnovo–NewCap: public relations, 201707 service existent IR + PR in France by NewCap 2017-07-07
Cobalt Light Systems–Agilent: investment, 201707 acquisition by Agilent for £40m in cash 2017-07-07
Axonics–Gilde Investment: investment, 201707 financing round Series C $20.5m 2nd closing incl new investor Gilde Healthcare 2017-07-06
Axonics–SEVERAL: investment, 201707 financing round Series C $20.5m 2nd closing bringing total Series C to $35m 2017-07-06
Cellnovo–SEVERAL: investment, 201707 capital increase €17.5m with 4.07m new shares at €4.3/share (discount of 27.2%) to institutional investors 2017-07-06
Zealand Pharma–SEVERAL: investment, 201707– US IPO of ADSs at Nasdaq Global Select Market FILED 2017-07-06
Ana Laboratories–Eurofins: investment, 201707 acquisition by Eurofins 2017-07-05
GSK–Exscientia: drug discovery, 201707– strategic collab pre-clinical research on up to 10 GSK targets 2017-07-02
Endress+Hauser–GUS Group: investment, 201707 acquisition of AJ Blomesystem GmbH by GUS Group 2017-07-01
Evotec–Hamburg (govt): grant, 201707– 201906 RnD grant from IFB Hamburg to develop AB-based cancer therapies with UKE 2017-07-01
mySugr–Roche: investment, 201706 acquisition of remaining shares by Roche 2017-06-30
Servier–Mérieux: cell therapy, 201706– collab research viral vectorization techn for allogenic CAR-T cell therapy production w Transgene 2017-06-29
Trinean–Unchained Labs: investment, 201706 acquisition of Trinean by Unchained Labs 2017-06-29
Unchained Labs–SEVERAL: investment, 201706 financing round Series C $13m incl existing investors Novo Ventures + Canaan Partnes + TPG Biotech 2017-06-29
Evotec–Censo Biotechnologies: stem cell technology, 201706–201905 strategic collab €na with Censo supplying iPS cell lines to Evotec 2017-06-28
Indi Molecular–Merck (DE): investment, 201706 financing round Series A totalling $11.5m led by Merck Ventures + Legend Capital 2017-06-28
Indi Molecular–SEVERAL: investment, 201706 financing round Series A $11.5m led by Merck Ventures + Legend Capital 2017-06-28
BioGeneration Ventures–EU (govt): investment, 201706 investment by EIF + other new investors bringing total capital of BGV III to €66m 2017-06-27
BioGeneration Ventures–SEVERAL: investment, 201706 investm by EIF + other new investors bringing total capital of BGV III to €66m with max target €75m 2017-06-27
CatalYm–BioGeneration Ventures: investment, 201706 CatalYm GmbH is existent investment of BGV III fund 2017-06-27
Escalier Biosciences–BioGeneration Ventures: investment, 201706 Escalier Biosciences BV is existent investment of BGV III fund 2017-06-27
LogicBio Therapeutics–Arix Bioscience: investment, 201706 financing round Series B totalling $45m incl lead investor Arix Bioscience 2017-06-27
LogicBio Therapeutics–LCF Rothschild: investment, 201706 financing round Series B totalling $45m incl new + co-investor EdRIP 2017-06-27
LogicBio Therapeutics–SEVERAL: investment, 201706 financing round Series B $45m led by Arix Bioscience + incl OrbiMed +EdRIP + Pontifax + SBI 2017-06-27
Mitoconix Bio–Arix Bioscience: investment, 201706 financing round Series A totalling $20m incl co-investor Arix Bioscience 2017-06-27
Mitoconix Bio–OrbiMed Advisors: investment, 201706 financing round Series A totalling $20m incl co-investor OrbiMed 2017-06-27
Mitoconix Bio–SEVERAL: investment, 201706 financing round Series A $20m led by Remiges Ventures + incl OrbiMed + Arix Bioscience + RMPG et al 2017-06-27
Scenic Biotech–BioGeneration Ventures: investment, 201706 Scenic Biotech BV is existent investment of BGV III fund 2017-06-27
Sensovation–Miltenyi Biotec: investment, 201706 acquisition by Milteny from HeidelbergCapital + KfW/tbg 2017-06-27
Servier–Plug and Play: digital health, 201706–202005 collab 3y incl WeHealth by Servier and Plug and Play Health & Wellness platform 2017-06-27
Takeda–JSR Corp: cell line development, 201706– commercial license to use Selexis’ SUREtechnology for developm of fusion proteins 2017-06-27
VarmX–BioGeneration Ventures: investment, 201706 seed financing round with lead investor BGV III + InnovationQuarter Capital 2017-06-27
VarmX–InnovationQuarter (NL): investment, 201706 seed financing round with lead investor BGV III + InnovationQuarter Capital 2017-06-27
VarmX–SEVERAL: investment, 201706 seed financing round with lead investor BGV III + InnovationQuarter Capital 2017-06-27
Antag Therapeutics–Novo Group: investment, 201706 seed financing €2.7m by Novo Seeds 2017-06-26
Genoma (IT)–Eurofins: investment, 201706 acquisition of Genoma Group Srl by Eurofins 2017-06-26
Ottobock–EQT: investment, 201706 EQT VII fund to acquire 20% stake from Otto Bock HealthCare GmbH valuing Ottobock at €3.15b 2017-06-24
Cellectis–SEVERAL: investment, 201706– proposed IPO $100m at Nasdaq of 100% sub Calyxt Inc while Cellectis intends to retain majority ownership 2017-06-23
ERICo (SI)–Eurofins: investment, 201706 acquisition of ERICo by Eurofins from Gorenje Group + two other shareholders 2017-06-23
DiaSorin–Qiagen: in vitro diagnostics, 201706– collab to adopt select Qiagen assays for use on Liaison platform 2017-06-22
Electrical Geodesics–Philips: investment, 201706– acquisition £29m in cash of EGI by Philips for £1.054/share ANNOUNCED 2017-06-22
GenSight Biologics–SEVERAL: investment, 201706 capital increase €22.5m €6/share with Europ + US institutional investors 2017-06-22
AlsaChim–Shimadzu: investment, 201706 acquisition €na of 100% of AlsaChim by Shimadzu Europe 2017-06-21
Compugen–JMP Securities: investor conference, 201706 supply service Compugen presents at JMP Securities 2017 Life Sciences Conference NY 2017-06-21
Evotec–Deutsche Bank: investor conference, 201706 supply service Evotec presents at dbAccess Berlin Conference 2017-06-21
FB Health–Invent Farma/Neuraxpharm: investment, 201706 acquisition €na of FB Health by Invent Farma/Neuraxpharm (formed 8/16 by Apax Partners) 2017-06-21
Ablynx–JMP Securities: investor conference, 201706 supply service Ablynx presents at JMP Securities 2017 Life Sciences Conference NY 2017-06-20
Argen-X–JMP Securities: investor conference, 201706 supply service Argenx presents at JMP Securities 2017 Life Sciences Conference NY 2017-06-20
Cell Medica–United Kingdom (govt): T cell therapy, 201706– acquisition rights €na to WT1-TCR cell therapy from CGT Catapult 2017-06-20
CRISPR Therapeutics–JMP Securities: investor conference, 201706 supply service CRISPR Tx presents at JMP Securities 2017 Life Sciences Conference NY 2017-06-20
Debiopharm–Almac: kinase inhibitor, 201706– license ww excl to Wee-1 kinase inhibitor programme of Almac Discovery 2017-06-20
Facio Therapies–Evotec: investment, 201706c financing round totalling €4.8m incl strategic investment by Evotec 2017-06-20
Facio Therapies–SEVERAL: investment, 201706c financing round €4.8m incl Evotec + members of intl FSHD community 2017-06-20
Idorsia–JnJ: investment, 201706 acquisition of 9.9% share in Idorsia by Cilag Holding AG via conversion of CFH135.4m convertable loan 2017-06-20
Novacyt–SEVERAL: investment, 201706 capital increase €3m net €2.8m w 3.53m new shares resulting in delution of 16% 2017-06-20
Oryzon Genomics–JMP Securities: investor conference, 201706 supply service Oryzon at JMP Securities 2017 Life Sciences Conference NY 2017-06-20
Parexel–Pamplona Capital: investment, 201706– acquisition $5b incl net debt in cash with $88.1/share ANNOUNCED 2017-06-20
APG Bio (CN)–Genomic Vision: genomic technology, 201706– distribution of molecular combing technology in Greater China by APG Bio 2017-06-19
Euroimmun–PerkinElmer: investment, 201706– acquisition $1.3b in cash ANNOUNCED 2017-06-19
Gamida Cell–SEVERAL: investment, 201706 financing round $40m led by new investor Shavit Capital 2017-06-19
Onxeo–SEVERAL: investment, 201706 capital increase €15m with 3.5m new shares at €4.25/share to US + European institutional investors 2017-06-19
Probiodrug–BIO (US): partnering conference, 201706 supply service Probiodrug Presents at BIO International Convention 2017-06-19
Takeda–Wilex: antibody-drug conjugates, 201706– collab developm of ADCs using ATACs for up to 3 targets Heidelberg Pharma + Millennium 2017-06-19
1 2 3 ... 42 43 44  next pagenext page



Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px